Skip to main content
Bharat Rasayan Limited logo

Bharat Rasayan Limited — Investor Relations & Filings

Ticker · BHARATRAS ISIN · INE838B01021 LEI · 335800NXICUEZQ62XR71 BSE.NS Manufacturing
Filings indexed 857 across all filing types
Latest filing 2025-10-30 Regulatory Filings
Country IN India
Listing BSE.NS BHARATRAS

About Bharat Rasayan Limited

https://www.bharatgroup.co.in/

Bharat Rasayan Limited specializes in the manufacturing of technical grade pesticides, formulations, and intermediates. The company’s product portfolio encompasses a broad range of insecticides, herbicides, and fungicides designed for effective crop protection. Operating advanced production facilities in Rohtak and Dahej, the organization maintains a strong focus on research and development to drive process innovation and product quality. Its business model emphasizes backward integration, ensuring a consistent supply of raw materials and cost-efficiency. Bharat Rasayan serves a diverse global clientele, providing high-quality chemical solutions to the agricultural sector. The company is recognized for its technical expertise, adherence to international safety standards, and commitment to sustainable manufacturing practices within the agrochemical space.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results/Other business matters
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying about an upcoming Board Meeting scheduled to consider and approve the un-audited financial results for the second quarter and six months ended September 30, 2025. It references SEBI regulations related to disclosure and insider trading window closure. The document does not contain any financial data or results itself, but is an announcement of the meeting where such results will be approved. The document length is short (1664 characters), and it serves as an intimation of a Board Meeting rather than the actual financial report or results. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and intimation rather than a full Interim Report or Earnings Release.
2025-10-30 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-10-30 English
Copy of Newspaper Publication
Regulatory Filings
2025-10-29 English
Shareholders meeting
Share Issue/Capital Change Classification · 95% confidence The document is a Notice of Extraordinary General Meeting (EGM) for Bharat Rasayan Limited. It details the agenda items for the EGM, including the subdivision/split of equity shares and the issue of bonus equity shares. The document includes resolutions to be passed, procedural notes about proxies, record dates, and instructions for shareholders. It does not contain financial statements or results but is a formal meeting notice with explanatory statements pursuant to Section 102 of the Companies Act, 2013. This fits the category of a shareholder meeting notice rather than a report or announcement of voting results. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA) because the main business is about share subdivision and bonus share issuance, which are capital changes requiring shareholder approval at the EGM.
2025-10-28 English
Stock split
Capital/Financing Update Classification · 95% confidence The document is a formal communication addressed to the Listing Compliance Manager of the National Stock Exchange of India. It reports the outcome of a Board of Directors meeting held on October 24, 2025, concerning corporate actions such as the subdivision of shares and the recommendation of a bonus issue of shares. The document references compliance with Regulation 30 of the SEBI Listing Regulations, which governs disclosure obligations for listed companies. It includes detailed annexures providing specifics about the share subdivision and bonus issue, including share capital pre- and post-transaction, rationale, and timelines. The document does not contain financial statements or detailed financial performance data but rather announces corporate actions and approvals by the Board, which are subject to shareholder approval. This type of document is an announcement of corporate actions and board decisions rather than a full financial report or earnings release. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as share subdivisions and bonus issues.
2025-10-24 English
Bonus
Capital/Financing Update Classification · 95% confidence The document is a formal communication addressed to the Listing Compliance Manager of the National Stock Exchange of India. It reports the outcome of a Board of Directors meeting held on October 24, 2025, where key corporate actions were approved, including a stock split (sub-division of shares) and a recommended bonus issue of shares. The document references compliance with Regulation 30 of the SEBI Listing Regulations, which governs disclosure of material events to stock exchanges. It includes detailed annexures providing specifics about the share subdivision and bonus issue, such as share capital pre- and post-transaction, rationale, and timelines. The document is an announcement of corporate actions and approvals by the Board, not a financial report or earnings release. It does not contain financial statements or detailed financial analysis but rather regulatory disclosures about capital structure changes and meeting outcomes. Therefore, the document fits best under Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as stock splits and bonus issues.
2025-10-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.